ARQT · Arcutis Biotherapeutics
AI read · Neutral
The AI's read
The filing gives no reason for the sale or any update about Arcutis's business. That leaves no clear link between this transaction and a change in the company's outlook.
An insider at Arcutis Biotherapeutics sold about $1.4 million worth of shares.
Neutral
An Arcutis insider sold about $1.4 million in shares, but the filing gives no reason or business update, so it does not show a change in the company's outlook.
Get alerts for ARQT
Follow Arcutis Biotherapeutics (ARQT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ARQTFree on the App Store and Google Play, or on the web.